Toxicity and safety
neutropenia, toxicity, toxicities, thrombocytopenia, Toxicity
THROMBOCYTOPENIA, NEUTROPENIA
Toxicity data are presented in Table Grade 2 and greater toxicities related (possibly, probably, or definitely) to palbociclib and/or ganitumab therapy (
Grade 3/4 AEs were observed in 80% of patients. The most common grade 3/4 AEs were neutropenia (8/10 patients), white blood cell count decreased (7/10 patients), and thrombocytopenia (5/10 patients). No patients were removed from the study due to toxicity.